ONS Lobbies for Breast Cancer Screening Act in Congress
Alongside congressional representatives Debbie Wasserman Schultz and Susan Brooks, ONS and other organizations are lobbying for support of the Protecting Access to Lifesaving Screenings (PALS) Act. This legislation would push insurance companies—along with the Veterans Health Administration—to provide access and coverage to breast cancer screenings for women aged 40–49.
The Role of Acupuncture in Treating Hot Flashes in Breast Cancer Survivors
Hot flashes, also known as hot flushes, are marked by periods of sudden, intense feelings of warmth that begin at the chest and radiate to the neck and face, along with flushing, sweating, and heart palpitations, lasting several seconds to minutes. Compared to healthy postmenopausal women, breast cancer patients and survivors are prone to experiencing more severe and longer-lasting hot flashes. A bothersome symptom, hot flashes can occur anytime during a 24-hour period, but those occurring at night are most troubling because they interfere with sleep. Sleep deprivation negatively impacts daytime functioning as well as pain, fatigue, depression, and anxiety levels, diminishing quality of life significantly.
FDA Broadens Palbociclib Indication in Breast Cancer
On March 31, 2017, the U.S. Food and Drug Administration (FDA) granted regular approval to palbociclib for the treatment of hormone receptor (HR)‑positive, human epidermal growth factor receptor 2 (HER2)‑negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
Antidepressant May Relieve Joint Pain From Aromatase Inhibitors
The antidepression drug duloxetine, which is approved to treat depression, anxiety, fibromyalgia, and diabetes nerve pain, may also relieve treatment-induced joint pain in breast cancer survivors receiving aromatase inhibitor therapy, according to the results of a study presented at the San Antonio Breast Cancer Symposium.
FDA Approves Ribociclib for Breast Cancer Treatment
On March 13, 2017, the U.S. Food and Drug Administration (FDA) approved ribociclib (KISQALI®, Novartis Pharmaceuticals Corp.), a cyclin-dependent kinase 4/6 inhibitor, in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
Cancer Deaths Fall 25% Since 1991
Research, treatment, and technology surges throughout the 1990s have led to a 25% reduction in cancer mortality rates since 1991, according to the American Cancer Society’s (ACS’s) latest Cancer Statistics, 2017, report (Siegel, Miller, & Jemal, 2016). The decline in cancer-related deaths accounts for more than 2.1 million lives saved between 1991 and 2014.
The Case of the Breast Cancer Biology
Molly is a 48-year-old biology professor at a prestigious university. She was recently diagnosed with stage II invasive ductal carcinoma. She is referred to Anna, the breast nurse navigator, for breast cancer education and coordination of care.
Mammography Cutoffs Should Be Based on Individual Health History
Researchers conducting the largest study to date on screening mammography outcomes have found no evidence to support stopping mammography screenings at a certain age. The findings were presented at the 2016 Radiological Society of North America annual meeting.
How Nurses Can Help Women Adhere to Oral Adjuvant Breast Cancer Treatment
Sentinel Node Dissection Sufficient for Localized Breast Cancer
Gene Expression Helps Predict Benefit From Adjuvant Chemo for Breast Cancer
Why More Women Are Choosing Bilateral Mastectomies
Palbociclib Plus Letrozole Improves Survival in Advanced Breast Cancer
NIH Conducts Largest Study of Breast Cancer Genetics in African American Women
ACOS Updates Standards for Breast Cancer Program Accreditation
Beyond Pink: Sharing Our Metastatic Breast Cancer Story
ONS Strategic Sponsor Launched in 2015, Beyond Pink: Sharing Our Metastatic Breast Cancer Story campaign was created based on feedback from the metastatic breast cancer (MBC) community that there is a need for more tailored information and resources specific to their disease. Beyond Pink offers tools and education to help those living with MBC better manage life as it relates to their diagnosis.
Study Links Bladder Cancer Subtype to Breast Cancer
ONS Members Deliver Presentation at Breast Cancer Conference in Singapore
Imaging Tests Are Overused in Early-Stage Breast Cancer
Periodontal Disease May Increase Breast Cancer Risk, Especially in Women Who Smoke
Lidocaine Reduces Pain During Sexual Intercourse for Breast Cancer Survivors
The Case of the Cancer Treatment Confusion
Combination Vaccine and Docetaxel May Improve Survival for Metastatic Breast Cancer
Online Tool Helps Women With Mammogram Decisions
Breast Cancer Screening Guidelines Make the News Again
There are numerous activities to promote breast cancer awareness. My youngest daughter, Elaine, is a nursing student who also swims for the Saint Louis University Billikens. During October, the entire team, men and women donned pink caps and shirts instead of their typical bright blue to promote awareness about breast cancer. The team was unified on this one, and I have no doubt it made people stop and think. Anything that makes people think about the early detection of breast cancer is a good thing.